Onconetix announces 1-for-85 reverse stock split effective June 13 to regain Nasdaq compliance

Onconetix, Inc.

Reverse split 1-for-85 effective June 13, 2025; outstanding shares reduced from ~44.4M to ~521,863.
Split intended to regain Nasdaq minimum $1.00 bid price compliance; no change to authorized shares.
New CUSIP 68237Q203; trading symbol ONCO unchanged.
Promissory note of $147,058.82 issued to Keystone Capital Partners with $22,059 OID, subordinated to Veru debt, due by March 5, 2026.

item 1.01item 2.03item 3.03item 5.03item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.